354813-19-7 Usage
Uses
Used in Pharmaceutical Industry:
Balicatib is used as a therapeutic agent for the treatment of osteoporosis. Its application is based on its ability to inhibit Cathepsin K, a key enzyme involved in bone resorption. By reducing the activity of Cat K, Balicatib can help slow down bone loss and improve bone density, offering a potential treatment option for patients suffering from osteoporosis.
Additionally, Balicatib's inhibitory effect on Cathepsin K may also have implications for other bone-related conditions and diseases, suggesting potential applications in broader therapeutic areas within the pharmaceutical industry. However, further research and clinical trials would be necessary to explore and validate these additional uses.
Check Digit Verification of cas no
The CAS Registry Mumber 354813-19-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,5,4,8,1 and 3 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 354813-19:
(8*3)+(7*5)+(6*4)+(5*8)+(4*1)+(3*3)+(2*1)+(1*9)=147
147 % 10 = 7
So 354813-19-7 is a valid CAS Registry Number.
354813-19-7Relevant academic research and scientific papers
Dipeptide nitrile cathepsin K inhibitors
-
, (2008/06/13)
Dipeptide nitrile Cathepsin K inhibitors of formula I, and pharmaceutically acceptable salts or esters thereof In which R1 and R2 are independently H or C1-C7lower alkyl, or R1 and R2 toget
